Regulatory Rapporteur July/August 2011
Volume 8 Issue 7
In This Issue
- FOCUS: CRITICAL STEPS FOR ADVANCED THERAPIES
- PLUS:
- Classifications of topical treatments
- The IVD medical devices directive
- Lifecycle management
Please login to download articles. Non-members may download the Focus article.
| Title | Download | Category | Size | File |
|---|---|---|---|---|
| Regulatory Rapporteur July/August 2011 | Members | Full Issue | 3MB | |
| Current challenges in the development of novel cell-based medicinal products | Public | 846KB | ||
| An interview with Wilfried Dalemans, Chief Technical Officer and Vice President Regulatory Affairs at Tigenix | Members | 620KB | ||
| EU regulatory updates during March-June 2011 | Members | 471KB | ||
| Guest editorial - Risk, GMP and hospital exemptions | Members | 470KB | ||
| Lifecycle management - Renewals, risk management and pharmacovigilance | Members | 736KB | ||
| Manufacture of advanced therapies: Academia meets industry | Members | 521KB | ||
| Risk management throughout the development of advanced therapy medicinal products | Members | 750KB | ||
| The Medical Devices Exchange | Members | 518KB | ||
| Topical treatments: Pharmaceutical, medical or cosmetic? | Members | 800KB |
